UNDERSTANDING HEMOPHILIA A AND B DRUG DOSAGE ADMINISTRATION PATTERNS
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 发起方
- Pfizer
- 入组人数
- 11
- 试验地点
- 3
- 主要终点
- Resource Utilization Pattern
研究概览
简要总结
Study Design
A prospective observational, cross-sectional epidemiological study in U.S. site-based clinical practice settings.
30 sites will enroll approximately 300 patients
Participating patients - or their caregiver in the case of patients under the age of 18 - will be consented to participate.
Physicians complete a retrospective chart review on each enrolled patient.
Patients will complete a one-time study questionnaire.
详细描述
Study recruitment was stopped due to difficulty in enrolling the targeted number of patients on March 21, 2018. Subjects currently enrolled into the study have completed the study as per protocol. There were no safety concerns involved in the decision to stop enrollment.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Other
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Hemophilia B
real world administration patterns and resource utilization implications
干预措施: Hemophilia B standard half-life (Drug)
Hemophilia B
real world administration patterns and resource utilization implications
干预措施: Hemophilia B extended half-life (Drug)
Hemophilia A
real world administration patterns and resource utilization implications
干预措施: Hemophilia A standard half-life (Drug)
Hemophilia A
real world administration patterns and resource utilization implications
干预措施: Hemophilia A extended half-life (Drug)
结局指标
主要结局
Resource Utilization Pattern
时间窗: From baseline up to end of study (6 months)
Dosing Pattern
时间窗: From baseline up to end of study (6 months)
次要结局
未报告次要终点